Prominent angiopathologic events associated with ischemia and hypertrophy, including tumorigenesis, are accompanied by secretion of growth factors from transformed cells which induce localized proliferation of normal tissue. Growth responses associated with endothelial structural integrity quantitatively reflects metastatic potential of tumors and the importance of angiogenesis. The direct stimulation of endothelial cell proliferation is the presumed responsibility of the heparin-binding growth factor (HBGF) family of polypeptides. HBGF-1, both a potent mitogen for mesoderm-derived cells in vitro and a hormonal inducer of angiogenesis in vivo, does not contain a recognizable signal peptide for secretion. The biological significance of this feature is related to HBGF-1 signal transduction processes: (a) interaction with a high affinity receptor, and (b) nuclear localization following receptor-mediated internalization. Localization within the nucleus anticipates that HBGF-1 may induce and sustain gene expression events that define the transformation potential of this growth factor. Deletion of the nuclear translocation sequence has generated a mutated form of HBGF-1 that is capable of receptor binding but unable to signal DNA synthesis or cell division, thereby suggesting natural antiangiogenic behavior. We hypothesize that HBGF-1 mediates its transforming potential through an extracellular pathway, which can be inhibited in vivo by receptor-competent, mitogenically inactive mutant forms of this growth factor. To rigorously define the biological properties of these polypeptides, the gene for different structural forms of HBGF-1 will be transduced into cells associated with vascular structure using retrovirally-mediated techniques. The interrelationship between the signal peptide and nuclear translocation sequence and their responding biological cascades will be evaluated to define molecular indicators of angiogenic responses during experimental tumorigenesis. Furthermore, the molecular mechanisms underlying the association between angiogenesis and perpetuation of proliferative lesions will be characterized in the complex environment of the living organism. Transplantation of transduced cells into a well-defined fiber implant model will be used to experimentally perturb and modulate a localized, site-specific biological process, thereby serving as a window to angiopathic phenomena and mechanisms to inhibit these processes. The availability of well-defined antibody and nucleic acid probes permits the dissection of responding genetic events at the molecular level using in situ analysis of mRNA and protein expression by transduced cell in vitro and in vivo. While the precise involvement of cytokines, growth factors and other gene products are not known, the cumulative resources, reagents and techniques within this application will elucidate detailed characteristics reflective of pathological angiogenesis and provide a rational design for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL045990-05
Application #
2332493
Study Section
Pathology A Study Section (PTHA)
Project Start
1993-02-01
Project End
1998-03-31
Budget Start
1997-02-06
Budget End
1998-03-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Biochemistry
Type
Schools of Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Olave, Nelida; Nicola, Teodora; Zhang, Wei et al. (2012) Transforming growth factor-? regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure. Am J Physiol Lung Cell Mol Physiol 302:L857-65
Ambalavanan, Namasivayam; Nicola, Teodora; Hagood, James et al. (2008) Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Am J Physiol Lung Cell Mol Physiol 295:L86-95
Ambalavanan, Namasivayam; Nicola, Teodora; Li, Peng et al. (2008) Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr Res 63:26-32
Ambalavanan, Namasivayam; Li, Peng; Bulger, Arlene et al. (2007) Endothelin-1 mediates hypoxia-induced increases in vascular collagen in the newborn mouse lung. Pediatr Res 61:559-64
Zhang, Pei; Greendorfer, Jessica S; Jiao, Jing et al. (2006) Alternatively spliced FGFR-1 isoforms differentially modulate endothelial cell activation of c-YES. Arch Biochem Biophys 450:50-62
Chen, Yiu-Fai; Feng, Ji-An; Li, Peng et al. (2006) Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. J Appl Physiol 100:564-71
Chen, Yiu-Fai; Feng, Ji-An; Li, Peng et al. (2006) Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling. Life Sci 79:1357-65
Cassina, Patricia; Pehar, Mariana; Vargas, Marcelo R et al. (2005) Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 93:38-46
Ambalavanan, Namasivayam; Bulger, Arlene; Murphy-Ullrich, Joanne et al. (2005) Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling. Pediatr Res 57:631-6
Li, Peng; Oparil, Suzanne; Feng, Wenguang et al. (2004) Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol 97:1550-8; discussion 1549

Showing the most recent 10 out of 51 publications